Investigation Report on China Pranoprofen Market, 2010-2019
Market Reports On China
http://www.marketreportsonchina.com
Summary According to the 2013 Health Statistical Bulletin, outpatients totaled 62.8312 million in China in 2013. As computer pervades into work and life, eye disease cases grow byScope millions each year, which leads to the expansion of ophthalmic drug market. The report provides market analysis, information and insights, including: Pharma Corporation Originally discovered byin-depth Welfide (Mitsubishi Tanabe formerly known as Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory drug, pranoprofen was later developed into eye drop by Senju Pharmaceutical Co., Ltd under the trade name of pranopulin for the treatment of inflammation of outercoverage eyeof theortravelanterior segment � A detailed and tourism industry in China of the eye like blepharitis, conjunctivitis and keratitis. In 1999, pranoprofen eye drop was approved by CFDA to enter the Chinese market for clinical use, followed by product from Shandong Haishan Pharmaceutical Co., and Guangzhou Kangqiao Hanpu � A comprehensive analysis of the airlines marketLtd in China Pharmaceutical Co., Ltd in 2009 and product of in 2013.
� Profile of the top airlines operating in China
Pranoprofen develops fast after entering China, sales value rising from CNY 64.04 million in 2013 to CNY 74.39 million in 2014 with a year-on-year growth of 16.2% and CAGR during the period of 2010-2014 reaching 38.7%. As computer pervades into work and life, the incidence of eye disease keeps rising, which leads to the vast demand for pranoprofen in China. Currently, pranoprofen in the Chinese market mainly come from the following three enterprises: Senju Pharmaceutical Co., Ltd, Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd, among which Senju Pharmaceutical Co.,Ltd had the largest market share of 89.38% which dropped from 90.59% in 2013 due to Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltds entering into the market with sales reaching CNY 66.49 million in 2014. Domestic drug is expected to occupy an increasingly large share in the next few years.
Readers can get at least the following information from this report: -market size of sodium pranoprofen in China -competitive landscape of sodium pranoprofen in Chinese market -price of sodium pranoprofen made by different enterprises in China -market outlook of sodium pranoprofen in China
The author suggests the following groups of people purchase this report: - manufacturers of ophthalmic drugs -investors/ research institutions interested in Chinese medicine market -any interest in the Chinese medicine market, please contact for customized survey service
Table Of Content 1 Related Concepts of Pranoprofen 2 Market Profile of Pranoprofen in China 3 Survey of Pranoprofen Sales in China, 2010-2014 4 Survey of Major Pranoprofen Manufacturers Market Share in China, 20102014 5 Survey of Dosage Forms of Pranoprofen in China, 2010-2014 6 Reference Price of Pranoprofen in Chinese Hospitals in 2014 7 Major Manufacturers of Pranoprofen in Chinese Market, 2010-2014
To view the full Executive Summary and Table of Contents, please visit:
Investigation Report on China Pranoprofen Marke Contact Us : Market Reports On China Contact No : +91 2227810772, 27810773 Email id : info@marketreportsonchina.com Website : http://marketreportsonchina.com/